DRUG · Mapped RxNorm record
Degarelix
Normalized identity: degarelixView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Trial of Degarelix in Patients With Prostate Cancer
NCT00946920
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Goserelin acetate
Normalized identity: goserelin acetateView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Trial of Degarelix in Patients With Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
DegarelixDRUG · verified · RxNorm: degarelix
Goserelin acetateDRUG · verified · RxNorm: goserelin acetate
Sponsors & collaborators
Ferring Pharmaceuticalslead sponsor
Mapped research locations
Saint PetersburgRussia6BucharestRomania4BudapestHungary3PragueCzechia3Mexico CityMexico3TorontoOntario, Canada2MoscowRussia2DallasTexas, United States1San AntonioTexas, United States1DurhamNorth Carolina, United States1Washington D.C.District of Columbia, United States1IndianapolisIndiana, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00946920 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.